Steward Partners Investment Advisory LLC Invests $122,000 in InMode Ltd. (NASDAQ:INMD)

Share on StockTwits

Steward Partners Investment Advisory LLC bought a new position in InMode Ltd. (NASDAQ:INMD) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 5,700 shares of the healthcare company’s stock, valued at approximately $122,000.

Separately, Patriot Financial Group Insurance Agency LLC purchased a new position in shares of InMode in the third quarter worth $32,000. Institutional investors own 0.55% of the company’s stock.

InMode stock opened at $40.44 on Friday. The company has a current ratio of 4.23, a quick ratio of 3.89 and a debt-to-equity ratio of 0.01. InMode Ltd. has a 52-week low of $13.06 and a 52-week high of $43.64. The company’s fifty day simple moving average is $27.84.

InMode (NASDAQ:INMD) last issued its earnings results on Tuesday, November 5th. The healthcare company reported $0.42 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.29 by $0.13. The business had revenue of $40.01 million for the quarter, compared to the consensus estimate of $35.74 million. During the same quarter in the previous year, the company earned $0.26 earnings per share. The firm’s revenue was up 57.4% on a year-over-year basis. On average, equities research analysts predict that InMode Ltd. will post 1.38 earnings per share for the current fiscal year.

INMD has been the topic of a number of recent research reports. Zacks Investment Research raised shares of InMode from a “hold” rating to a “strong-buy” rating and set a $45.00 price target on the stock in a research note on Friday. Canaccord Genuity initiated coverage on shares of InMode in a research note on Tuesday, September 3rd. They set a “buy” rating and a $30.00 price target on the stock. Barclays upped their price target on shares of InMode from $27.00 to $45.00 and gave the company an “overweight” rating in a research note on Wednesday. UBS Group initiated coverage on shares of InMode in a research note on Tuesday, September 3rd. They set a “buy” rating and a $28.00 price target on the stock. Finally, Robert W. Baird reaffirmed an “outperform” rating and set a $45.00 price target (up previously from $27.00) on shares of InMode in a research note on Wednesday. Four investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. InMode presently has an average rating of “Buy” and an average price target of $38.60.

InMode Profile

InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radio frequency technologies. The company offers minimally-invasive aesthetic medical products for procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments.

Read More: What does relative strength index mean?

Want to see what other hedge funds are holding INMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InMode Ltd. (NASDAQ:INMD).

Institutional Ownership by Quarter for InMode (NASDAQ:INMD)

Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.